Concentration effect modelling with converting enzyme inhibitors in man.
AW Kelman, JL Reid, JA Millar - British Journal of Clinical …, 1983 - ncbi.nlm.nih.gov
The investigation of pharmacokinetic and phar-macodynamic relationships after converting
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
[引用][C] Concentration effect modelling with converting enzyme inhibitors in man
AW Kelman, JL Reid, JA Millar - British Journal of Clinical …, 1983 - Wiley Online Library
The investigation of pharmacokinetic and phar-macodynamic relationships after converting
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
[PDF][PDF] Concentration effect modelling with converting enzyme inhibitors in man.
AW Kelman, JL Reid, JA Millar - British Journal of Clinical …, 1983 - europepmc.org
The investigation of pharmacokinetic and phar-macodynamic relationships after converting
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
enzyme inhibitors has been limited up until now. The drug most widely available, captopril …
[引用][C] Concentration effect modelling with converting enzyme inhibitors in man
AW Kelman, JL Reid, JA Millar - British journal of clinical …, 1983 - pubmed.ncbi.nlm.nih.gov